{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:07Z","timestamp":1753890967294,"version":"3.41.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cytomegalovirus (CMV) infection is a relevant threat to heart-transplanted patients during the first year after surgery, leading to increased morbidity and, in some cases, mortality. This <jats:italic>proof-of-concept<\/jats:italic> study aims to assess the transcriptomic profile of CMV infection in cardiac transplanted patients as a new diagnostic approach to discriminate infection and Acute Cellular Rejection (ACR) on EMB specimens.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a microarray-based messenger RNA (mRNA) and micro-RNA (miRNA) profiling. We analyzed three patient groups in the setting of CMV viremia and inflammatory infiltrate: a control group (n=5), an ACR group (n=5), and an infection group (n=6). Differentially expressed mRNA and miRNA were further investigated through bioinformatic pathway analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Focusing on infection vs rejection comparison, we investigated the role of the 18 differentially expressed mRNAs and the 12 miRNAs with the most significative p-value (gene level fold change, FC &amp;lt;-2 or &amp;gt;2, p-value &amp;lt;0.05). Based on the bioinformatic analysis, we explored the regulatory effects of these miRNAs on the mRNA pathways independently identified in the same samples. The results showed that two genes, IL7R and GZMK (-38.63 and -3.15 FC, respectively), and two miRNAs, mir-93-5p and mir-345-5p (-2.63 and -2.18 FC, respectively), are differentially expressed in infection and can be exploited to differentiate CMV-positive from ACR-positive EMB specimens, reaching an AUC of 0.87 and an accuracy of 91% at cross-validation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We have identified a distinctive combined molecular profile of mRNAs and miRNAs for infection in post-cardiac transplant follow-up. Based on IL7R, GZMK, mir-93-5p, and mir-345-5p we suggest a novel possible workflow to distinguish infection, where those markers are downregulated, from rejection, where they are overexpressed, on EMB specimens. This analysis showed good accuracy and promising predictive performance. The future combined analysis of these genes and these miRNAs through user-friendly techniques, such as quantitative PCR, could reduce turn-around time and improve our diagnostic power for distinguishing CMV infection from ACR in EMB specimens.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1581151","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:10:43Z","timestamp":1747368643000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic profiling of cytomegalovirus infection in cardiac transplantation: proof-of-concept for a new strategy in tissue markers application"],"prefix":"10.3389","volume":"16","author":[{"given":"Ilaria","family":"Barison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Perazzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Giarraputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Vedovelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia Anna","family":"Minuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Tessari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Pradegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Tona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"Gerosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Mandruzzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Abate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marny","family":"Fedrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1199684","article-title":"Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update","volume":"17","author":"Potena","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.09.035","article-title":"Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: effect of preemptive therapy","volume":"44","author":"Mendez-Eirin","year":"2012","journal-title":"Transplant Proc"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1171197","article-title":"Human cytomegalovirus and Epstein\u2013Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients","volume":"14","author":"Saldan","year":"2023","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00316.x","article-title":"The role of viruses in cardiac allograft vasculopathy","volume":"4","author":"Valantine","year":"2003","journal-title":"Am J Transpl"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2010.00573.x","article-title":"Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study","volume":"13","author":"Delgado","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328259c33b","article-title":"Cytomegalovirus-associated allograft rejection in heart transplant patients","volume":"20","author":"Potena","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients\u2014Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transpl"},{"key":"B9","doi-asserted-by":"publisher","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann Intern Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv682","article-title":"Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II","volume":"37","author":"Crespo-Leiro","year":"2016","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/TP.0000000000004323","article-title":"The molecular microscope diagnostic system: assessment of rejection and injury in heart transplant biopsies","volume":"107","author":"Halloran","year":"2023","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049098","article-title":"Cell-free DNA to detect heart allograft acute rejection","volume":"143","author":"Agbor-Enoh","year":"2021","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.062847","article-title":"Selection and interpretation of molecular diagnostics in heart transplantation","volume":"148","author":"Goldberg","year":"2023","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.05.029","article-title":"Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System","volume":"36","author":"Halloran","year":"2017","journal-title":"J Heart Lung Transpl"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013111149","article-title":"Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection","volume":"25","author":"Loupy","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL) -2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2010","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35365","article-title":"Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor \u03b1 -chain are excluded from the analysis","volume":"118","author":"Michel","year":"2008","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nri2970","article-title":"Harnessing the biology of IL-7 for therapeutic application","volume":"11","author":"MacKall","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2012.04.010","article-title":"IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis","volume":"24","author":"Carrette","year":"2012","journal-title":"Semin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1038\/s41467-018-06804-y","article-title":"IL-7 receptor blockade blunts antigen-speci fi c memory T cell responses and chronic in fl ammation in primates","volume":"9","author":"Belarif","year":"2018","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.06.007","article-title":"Interleukin-7: Fuel for the autoimmune attack","volume":"45","author":"Dooms","year":"2013","journal-title":"J Autoimmun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12756","article-title":"Guiding postablative lymphocyte reconstitution as a route toward transplantation tolerance","volume":"14","author":"Piotti","year":"2014","journal-title":"Am J Transpl"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI66287","article-title":"IL-7 receptor blockade following T cell depletion promotes long-term allograft survival","volume":"124","author":"Mai","year":"2014","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M806716200","article-title":"Granzyme K displays highly restricted substrate specificity that only partially overlaps with granzyme A *","volume":"284","author":"Bovenschen","year":"2009","journal-title":"J Biol Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/pr500968d","article-title":"Substrate specificities of the granzyme tryptases A and K","volume":"13","author":"Plasman","year":"2014","journal-title":"J Proteome Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev.immunol.26.021607.090404","article-title":"Death by a thousand cuts: granzymes pathways of programmed cell death","volume":"26","author":"Chowdhury","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.09.031","article-title":"Granzyme K expressed by classically activated macrophages contributes to inflammation and impaired remodeling","volume":"139","author":"Turner","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"109804","DOI":"10.1016\/j.cellsig.2020.109804","article-title":"Granzymes in cardiovascular injury and disease","volume":"76","author":"Zeglinski","year":"2020","journal-title":"Cell Signal"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56 bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/febs.2016.283.issue-9","article-title":"Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1","volume":"283","author":"Sharma","year":"2016","journal-title":"FEBS J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.119","article-title":"Mir-106b and mir-93 regulate cell progression by suppression of pten via pi3k\/akt pathway in breast cancer","volume":"8","author":"Li","year":"2017","journal-title":"Cell Death Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.23.13513","article-title":"The lipid phosphatase activity of PTEN is critical for its tumor supressor function","volume":"95","author":"Myers","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5369.1614","article-title":"Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN","volume":"280","author":"Tamura","year":"1998","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4161\/cc.22670","article-title":"MiR-93 enhances angiogenesis and metastasis by targeting LATS2","volume":"11","author":"Fang","year":"2012","journal-title":"Cell Cycle"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.465","article-title":"MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-\u03b28","volume":"30","author":"Fang","year":"2011","journal-title":"Oncogene"},{"key":"B36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.toxlet.2022.09.008","article-title":"miR-345\u20135p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression","volume":"370","author":"Wang","year":"2022","journal-title":"Toxicol Lett"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106522","article-title":"MicroRNA-345-5p acts as an anti-inflammatory regulator in experimental allergic rhinitis via the TLR4\/NF-\u03baB pathway","volume":"86","author":"Liu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2011.66","article-title":"Expression of \u03b3-chain cytokine receptors on CD8+ T cells in HIV infection with a focus on IL-7R\u03b1 (CD127)","volume":"90","author":"Crawley","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21365","article-title":"Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence","volume":"44","author":"Golden-Mason","year":"2006","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000191919.24185.46","article-title":"Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV","volume":"19","author":"Boutboul","year":"2005","journal-title":"AIDS"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535111","article-title":"IL-7R\u03b1 expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation","volume":"36","author":"Koesters","year":"2006","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677707","article-title":"Intracellular and extracellular roles of granzyme K","volume":"12","author":"Bouwman","year":"2021","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.1098200","article-title":"NK- and T-cell granzyme B and K expression correlates with age, CMV infection and influenza vaccine-induced antibody titres in older adults","volume":"3","author":"Verschoor","year":"2023","journal-title":"Front Aging"},{"key":"B44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/01.tp.0000229039.87735.76","article-title":"Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection","volume":"82","author":"Potena","year":"2006","journal-title":"Transplantation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e13069","DOI":"10.1111\/tid.2019.21.issue-3","article-title":"Cytomegalovirus viremia in lung transplantation during and after prophylaxis","volume":"21","author":"Chang","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"101226","DOI":"10.1016\/j.trim.2019.101226","article-title":"Low dose valganciclovir as cytomegalovirus prophylaxis in post-renal transplant recipients induced with alemtuzumab: A single-center study","volume":"56","author":"Korneffel","year":"2019","journal-title":"Transpl Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.3138","article-title":"Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: A randomized clinical trial","volume":"323","author":"Singh","year":"2020","journal-title":"JAMA  J Am Med Assoc"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000168454.68139.0a","article-title":"Cytomegalovirus-related complications in human hand transplantation","volume":"80","author":"Schneeberger","year":"2005","journal-title":"Transplantation"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004132","article-title":"Cytomegalovirus-related complications and management in facial vascularized composite allotransplantation: an international multicenter retrospective cohort study","volume":"106","author":"Kauke-Navarro","year":"2022","journal-title":"Transplantation"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/frtra.2024.1366243","article-title":"Immunosuppressive strategies in face and hand transplantation: a comprehensive systematic review of current therapy regimens and outcomes","volume":"3","author":"Huelsboemer","year":"2024","journal-title":"Front Transpl"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1581151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:10:44Z","timestamp":1747368644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1581151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2025.1581151"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1581151","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"article-number":"1581151"}}